Female Pattern Hair Loss (Androgenetic Alopecia): Signs and Options

By Ciobanu Sebastian, Founder of Folliq · Updated 6 October 2026 · Sources linked in the text

Female pattern hair loss (androgenetic alopecia) is gradual thinning across the top of the scalp: the part widens and the crown loses density while the front hairline usually stays in place. It is the most common cause of thinning hair in women, it progresses slowly over years, and the earlier it is recognized, the more hair there is to work with. Options range from minoxidil and prescription antiandrogens to red-light devices, microneedling and PRP; here is how strong the evidence is for each.

Key takeaways

• Female pattern hair loss shows as a widening part and a thinner crown with the front hairline kept, and it is graded on the three-stage Ludwig scale.
• It becomes more common with age: in an Australian community study, mid-frontal thinning affected 57% of women aged 80 and over.
• The cause is miniaturization of follicles that are genetically sensitive to androgens; most women with it have normal blood androgen levels.
• Topical minoxidil has the largest trial in women (381 women over 48 weeks); red-light devices, microneedling and PRP are supported by smaller controlled trials.
• Every option works on a months-long clock: take a first photo check at 90 days and judge over 6 to 12 months.

What is female pattern hair loss?

Female pattern hair loss is a change in what each follicle produces, not a sudden increase in shedding. Over successive cycles, an affected follicle spends less time in the anagen growth phase and grows a finer, shorter hair each time.

This is called miniaturization: a thick terminal hair gradually becomes a fine, barely visible vellus hair. The follicle is still there and still working; it is producing a hair too fine to give coverage.

It is very common. A treatment review notes that fewer than 45% of women go through life with a full head of hair (Dinh & Sinclair 2007). In a community survey in Maryborough, Australia, mid-frontal thinning rose steadily with age and reached 57% of women and 73.5% of men aged 80 and over (Gan & Sinclair 2005).

How is female pattern hair loss different from male pattern hair loss?

The underlying process is the same, but the shape differs. Men typically lose hair at the temples and crown, graded on the Norwood scale; women usually thin diffusely across the top. In women the typical picture is:

• Diffuse thinning over the top of the scalp rather than loss concentrated at the temples or crown.
• A widening central part, often the first sign, sometimes called a "Christmas tree" pattern because it broadens toward the front.
• A preserved frontal hairline, usually a band of hair 1 to 3 cm deep even in advanced cases.
• Complete baldness is rare.

Because the front is kept, many women notice it first in a photo or under bright overhead light. A smaller group develop a male-type pattern with temple recession.

What are the Ludwig stages?

Dermatologists grade female pattern hair loss with the Ludwig scale, published in 1977. It has three grades, all with the frontal hairline intact.

The scale describes rather than predicts: many women stay at grade I or II for decades.

What causes it? DHT and miniaturization

The driver is dihydrotestosterone (DHT) acting on follicles with a genetic sensitivity to it. Women make testosterone too, at much lower levels than men, and the enzyme 5-alpha-reductase converts some of it to DHT in the skin and follicle, where it shortens anagen cycle after cycle.

Follicle sensitivity matters more than hormone levels. A dermatology review notes that the vast majority of women with pattern hair loss have normal androgen levels and that falling estrogen is thought to play a part; it describes the condition as one that "can be seen from early adulthood but commonly presents in menopause" (Kamp 2022).

How is female pattern hair loss diagnosed?

A dermatologist usually diagnoses it from the pattern plus dermoscopy, a magnified look at the scalp. The key finding is hair diameter diversity: many hairs are clearly finer than their neighbors because they are at different stages of miniaturization, while the back of the scalp is usually spared.

Blood tests do not diagnose pattern hair loss, but they rule out conditions that mimic or worsen it: ferritin, thyroid function (TSH) and vitamin D, plus an androgen panel if you have irregular periods, acne or new facial hair, to check for polycystic ovary syndrome. Our guide to which blood tests to ask for with hair loss explains each marker.

What are the options, and how strong is the evidence?

Topical minoxidil has the strongest evidence in women, followed by prescription antiandrogens and a group of devices and procedures supported by smaller controlled trials.

Minoxidil and antiandrogens

In a 48-week randomized trial, 381 women aged 18 to 49 applied 5% minoxidil, 2% minoxidil or placebo twice daily (Lucky 2004). The 5% solution beat placebo on hair count and on investigator and patient ratings, with more itching and unwanted facial hair than 2%. Results last while it is used; our article on minoxidil side effects and non-drug alternatives covers what to expect.

Spironolactone blocks androgen receptors and is prescribed off-label. In an open study, 80 women took spironolactone 200 mg daily or cyproterone acetate for at least 12 months, and 88% either improved or stayed stable (Sinclair 2005). It needs a prescription and monitoring of potassium and blood pressure.

Red-light therapy devices

Studies of red-light devices are the best-supported non-drug option here. In four sham-controlled trials, 141 women and 128 men used a red laser comb or a sham device three times a week for 26 weeks (Jimenez 2014). Terminal hair density rose by 18.4 to 25.7 hairs per cm² with the active devices versus 1.6 to 9.4 with sham, regardless of age or sex.

A helmet-style device has been tested in women specifically: 47 women used a 655 nm laser-and-LED helmet or a sham every other day for 16 weeks (Lanzafame 2014). Among the 42 who completed it, hair counts in the test area rose by an average of 100 hairs versus 24 with sham. Our guide to low-level light therapy, wavelength and dose explains how these devices are specified.

If you want an at-home red-light step that is easy to keep up, the Folliq Red Light Scalp Massager combines 24 red LEDs at 660 nm with sonic vibration and light-guide silicone bristles in a 6-minute session, typically 3 to 5 times a week. Its refillable 12 ml cartridge spreads your hair oil or serum evenly over the scalp as you go, so light, massage and topical become one routine.

For a hands-free option, our cordless red light cap reaches the whole scalp with red and near-infrared LEDs in a 10- or 20-minute session, 3 to 4 times a week, so you can read or work while it runs.

Microneedling

Microneedling has been studied mainly as an add-on to minoxidil. In 100 men with pattern hair loss, weekly 1.5 mm clinic microneedling plus 5% minoxidil raised the mean hair count by 91.4 over 12 weeks, versus 22.2 with minoxidil alone (Dhurat 2013). The trial enrolled men, so results in women have not been measured in that design.

At home, the standard is 0.5 mm needles, 2 to 3 times a week, never on consecutive days. The Folliq Scalp Derma Roller uses 540 titanium-coated 0.5 mm needles for exactly that routine: roll first on a clean, dry scalp, apply serum straight after, and keep roller and massager sessions on different days. Our guide to derma rolling needle size, frequency and safety covers technique and hygiene.

PRP and rosemary oil

A meta-analysis of nine randomized PRP trials with 238 patients found higher hair density than placebo at three and six months, while hair count and diameter did not differ significantly from placebo (Zhang 2023). Rosemary oil matched 2% minoxidil on hair counts over six months in 100 men aged 18 to 49, with less scalp itching (Panahi 2015); women were not included in that trial.

How long until you see a difference?

Expect months, not weeks. Hair grows about 1 cm (roughly half an inch) a month, and the trials above measured results at 16 to 48 weeks; Dinh & Sinclair note that a first response to medical treatment often takes 12 months or longer.

Photograph your part in the same light today, check again at 90 days, and judge over 6 to 12 months. Because miniaturized follicles are still present, early action has more to work with; our article on whether hair loss is reversible explains which types recover fully and which are managed long term.

Female pattern hair loss at different life stages

Pattern thinning can start in the twenties but most often becomes noticeable from the mid-forties, as falling estrogen shifts the balance toward androgens. In perimenopause it often overlaps with temporary shedding; our guide to perimenopause hair thinning explains how to tell them apart. After menopause it becomes slow, long-term change, covered in menopause hair loss: what changes and what helps. For thinning in men and women side by side, see hair thinning after 45: normal aging or something to check.

When to see a doctor

See a dermatologist early rather than late, and promptly if:

• Hair loss is sudden or comes out in patches.
• Your front hairline or eyebrows are receding, which can signal frontal fibrosing alopecia, a scarring condition that needs prompt treatment.
• You have scalp symptoms such as pain, burning, scaling or redness.
• You have signs of androgen excess: new facial hair, acne, irregular periods or a deepening voice.
• You have not had ferritin and thyroid function checked in the past year.

FAQ

Can female pattern hair loss be reversed?

It is managed rather than switched off. Treatments can slow or stop progression and, in many women, improve density, especially when started while miniaturized follicles are still producing hair. Results last while treatment continues.

At what age does female pattern hair loss start?

It can begin any time after puberty, but most women notice it from their forties onward. Thinning that starts very young, or comes with irregular periods or acne, is worth checking for polycystic ovary syndrome.

Does minoxidil work for women over 50?

The largest trial enrolled women aged 18 to 49, so its numbers apply most directly to that group. Dermatologists use minoxidil at all ages, and in Sinclair's antiandrogen study, age and menopause status did not predict response.

Can red light therapy help female pattern hair loss?

Sham-controlled trials of red-light devices around 655 nm recorded greater increases in hair density and hair count than sham over 16 to 26 weeks, including one trial run only in women. Choose a format you can fit into your week and judge it over 4 to 6 months.

Folliq products are cosmetic scalp-care products, not medical devices or medicines, and are not intended to diagnose, treat, cure or prevent any disease. The studies discussed here used clinical devices and preparations, which is why every Folliq product comes with 90 days to try it for yourself. If your hair loss is sudden, patchy or painful, see a dermatologist.

References

1. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. British Journal of Dermatology. 1977. PubMed 921894
2. Norwood OT. Male pattern baldness: classification and incidence. Southern Medical Journal. 1975. PubMed 1188424
3. Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. Journal of Investigative Dermatology Symposium Proceedings. 2005. PubMed 16382660
4. Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clinical Interventions in Aging. 2007. PubMed 18044135
5. Kamp E, Ashraf M, Musbahi E, DeGiovanni C. Menopause, skin and common dermatoses. Part 1: hair disorders. Clinical and Experimental Dermatology. 2022. PubMed 35796569
6. Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology. 2004. PubMed 15034503
7. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. British Journal of Dermatology. 2005. PubMed 15787815
8. Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. American Journal of Clinical Dermatology. 2014. PubMed 24474647
9. Lanzafame RJ, Blanche RR, Chiacchierini RP, et al. The growth of human scalp hair in females using visible red light laser and LED sources. Lasers in Surgery and Medicine. 2014. PubMed 25124964
10. Dhurat R, Sukesh M, Avhad G, et al. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. International Journal of Trichology. 2013. PubMed 23960389
11. Zhang X, Ji Y, Zhou M, et al. Platelet-rich plasma for androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials. Journal of Cutaneous Medicine and Surgery. 2023. PubMed 37533146
12. Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed. 2015. PubMed 25842469